Cargando…
iTRAQ-based proteomic profiling reveals protein alterations after traumatic brain injury and supports thyroxine as a potential treatment
Traumatic brain injury (TBI) is a primary cause of disability and death across the world. Previously, RNA analysis was widely used to study the pathophysiological mechanisms underlying TBI; however, the relatively low correlation between the transcriptome and proteome revealed that RNA transcription...
Autores principales: | Zhang, Zhongxiang, Yu, Jiangtao, Wang, Pengcheng, Lin, Lian, Liu, Ruining, Zeng, Rong, Ma, Haoli, Zhao, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839205/ https://www.ncbi.nlm.nih.gov/pubmed/33504361 http://dx.doi.org/10.1186/s13041-021-00739-0 |
Ejemplares similares
-
i-Tracker: For quantitative proteomics using iTRAQ™
por: Shadforth, Ian P, et al.
Publicado: (2005) -
Serum proteomics analysis and comparisons using iTRAQ in the progression of hepatitis B
por: PENG, LIANG, et al.
Publicado: (2013) -
Serum Proteome Alterations in Patients with Cognitive Impairment after Traumatic Brain Injury Revealed by iTRAQ-Based Quantitative Proteomics
por: Xiong, Xin-gui, et al.
Publicado: (2017) -
Proteomic analysis by iTRAQ-MRM of soybean resistance to Lamprosema Indicate
por: Zeng, Weiying, et al.
Publicado: (2017) -
iTRAQ-based proteomics reveals novel biomarkers of osteoarthritis
por: Ikeda, Daiki, et al.
Publicado: (2013)